BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/29/2015 5:40:00 PM | Browse: 1159 | Download: 2086
 |
Received |
|
2014-11-28 18:57 |
 |
Peer-Review Started |
|
2014-11-29 13:15 |
 |
To Make the First Decision |
|
2015-01-08 14:01 |
 |
Return for Revision |
|
2015-01-14 13:58 |
 |
Revised |
|
2015-01-20 16:29 |
 |
Second Decision |
|
2015-05-15 17:40 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-05-15 18:36 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-05-27 15:08 |
 |
Articles in Press |
|
2015-05-27 15:23 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-06-06 14:09 |
 |
Publish the Manuscript Online |
|
2015-06-29 17:40 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Radiology, Nuclear Medicine & Medical Imaging |
Manuscript Type |
Observational Study |
Article Title |
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization
|
Manuscript Source |
Invited Manuscript |
All Author List |
Antonio Orlacchio, Fabrizio Chegai, Stefano Merolla, Simona Francioso, Costantino Del Giudice, Mario Angelico, Giuseppe Tisone and Giovanni Simonetti |
Funding Agency and Grant Number |
|
Corresponding Author |
Antonio Orlacchio, MD, Department of Diagnostic and Molecular Imaging, Radiation Therapy and Interventional Radiology, University Hospital Tor Vergata, Viale Oxford 81, 00133 Rome, Italy. aorlacchio@uniroma2.it
|
Key Words |
Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Liver transplantation; Degradable starch microspheres; New-Milan-criteria; Recurrence-free survival; Locoregional therapies |
Core Tip |
Liver transplantation (LT) is the standard of care for select patients with hepatocellular carcinoma (HCC) and cirrhosis and recently more transplant centers use the new Milan criteria to assess the candidacy of HCC patients for LT. This manuscript reports a preliminary experience on the HCC treatment in liver transplant candidates without new-Milan-criteria, using a new technique of transcatheter arterial chemo-embolization with degradable starch microspheres transcatheter arterial chemoembolization (DSM-TACE). Providing a temporary embolization DSM-TACE allows to treat more patients with an impaired liver function reducing toxicity due to standard arterial embolization. Moreover good down-staging rates after repeated DSM-TACE were successfully achieved.
|
Publish Date |
2015-06-29 17:40 |
Citation |
Orlacchio A, Chegai F, Merolla S, Francioso S, Del Giudice C, Angelico M, Tisone G, Simonetti G. Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization. World J Hepatol 2015; 7(12): 1694-1700 |
URL |
http://www.wjgnet.com/1948-5182/full/v7/i12/1694.htm |
DOI |
http://dx.doi.org/10.4254/wjh.v7.i12.1694 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345